NCT06078007

Brief Summary

Background: Symptoms of depression and anxiety are prevalent among Spanish university students. Minimally guided online interventions have shown promise in reducing symptomatology and preventing increased mental distress. There is a need to evaluate the effectiveness of guided preventive mental health interventions for depression and anxiety in university students. Methods: two-arm multicenter randomized controlled trial (RCT), addressed to undergraduate students from 6 public universities with symptoms of depression and/or anxiety. Students will be evaluated through an online survey assessing mental health problems, use of mental health services, sociodemographic variables, self-perceived health, childhood and adolescent adversities, recent stressful events, social networks, personality and university experiences. A total of 600 students will be randomly assigned to: intervention group (guided E-health prevention intervention) or control group (treatment as usual with self-monitoring). The intervention, in app format, is based on principles of cognitive behavioral therapy, includes weekly feedback based on content and participation from a psychologist and self-monitoring. Assessments will take place post-intervention (up to 6 weeks), at 6 months and 12 months after randomization. The primary outcome will be the reduction of depressive or anxiety symptoms post-intervention, assessed with the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7) and the Patient Health Questionnaire-Anxiety and Depression Scale (PHQ-ADS). Secondary outcomes of the RCT will be mental wellbeing, academic stress, comorbid symptoms, and adherence. Analyses will be conducted on an intention-to-treat and per protocol basis. Discussion: The results of the PROMES-U RCT will provide valuable information on a guided preventive online intervention that could be delivered in the campus context. In addition, results will provide information on the positive impact of the intervention on other relevant factors involved in mental health among university students.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 28, 2023

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 11, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

October 25, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2025

Completed
Last Updated

October 31, 2024

Status Verified

October 1, 2024

Enrollment Period

1 year

First QC Date

September 28, 2023

Last Update Submit

October 29, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change of depressive symptoms

    The primary outcome will be the change of depressive symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Patient Health Questionnaire-9 (PHQ-9) and the Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The PHQ-9 range from 0 to 27, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe depression.

    Up to 6 weeks, at 6 months and 12 months after randomization

  • Change of anxiety symptoms

    The primary outcome will be the change of anxiety symptoms at post-intervention (up to 6 weeks), 6 months and 12 months post randomization, considering the minimal clinically relevant change in the scores of Generalized Anxiety Disorder -7 (GAD-7) he Patient Health Questionnaire Anxiety and Depression Scale (PHQ-ADS). The GAD-7 range from 0 to 21, higher scores mean a worse outcome. The PHQ-ADS range from 0 to 48 with higher scores indicating more severe anxiety.

    Up to 6 weeks and at 6 months and 12 months post randomization

Study Arms (2)

MyMoodCoach Intervention

EXPERIMENTAL
Behavioral: MyMoodCoach

Treatment-as-usual monitoring control group

NO INTERVENTION

Interventions

MyMoodCoachBEHAVIORAL

The MyMoodCoach prevention intervention is an evidence-based online intervention based on cognitive-behavioral therapy principles such as behavioral activation, problem solving and challenging negative thoughts.

MyMoodCoach Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible participants are all undergraduate students at the 6 participating universities and students followed in the PROMES-U observational study
  • Having 18 years of age or more
  • Having literacy in Spanish
  • Having access to a smartphone (Android or Apple)
  • With mild or moderate depression and/or anxiety symptoms screened (i.e., depression (5≤ (PHQ-9) ≤14); and/or anxiety (5≤ GAD-7 ≤14).

You may not qualify if:

  • Moderately severe or severe depression and/or anxiety (i.e., PHQ-9≥15 and/or GAD-7≥15)
  • High suicide risk
  • A history of severe psychiatric disorder (e.g., bipolar, psychosis)
  • Being on mental health treatment (i.e., medication, psychotherapy or other intervention)
  • Students with high suicide risk will receive a clinical alert recommending them to visit a specialist and a list of available mental health resources.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Miquel Roca

Palma de Mallorca, Balearic Islands, 07122, Spain

RECRUITING

Related Publications (1)

  • Ballester L, Gili M, Roca M, Forteza-Rey I, Soto-Sanz V, Vilagut G, Amigo F, Moreno-Kustner B, Mortier P, Piqueras JA, Portillo-Van Diest A, Rebagliato M, Rodriguez-Jimenez T, Alonso J; PROMES-U study group. Effectiveness of a guided mobile app intervention for depression and anxiety in university students (PROMES-U study): protocol of a multicenter randomized controlled trial. BMC Public Health. 2025 Nov 3;25(1):3740. doi: 10.1186/s12889-025-24752-3.

MeSH Terms

Conditions

DepressionAnxiety Disorders

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental Disorders

Study Officials

  • Jordi Alonso

    Hospital de Mar Medical Research Institute (IMIM)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

PROMES-U Study

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 28, 2023

First Posted

October 11, 2023

Study Start

October 25, 2024

Primary Completion

November 1, 2025

Study Completion

November 1, 2025

Last Updated

October 31, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations